BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

552 related articles for article (PubMed ID: 10657621)

  • 21. Inhibiting STAT5 by the BET bromodomain inhibitor JQ1 disrupts human dendritic cell maturation.
    Toniolo PA; Liu S; Yeh JE; Moraes-Vieira PM; Walker SR; Vafaizadeh V; Barbuto JA; Frank DA
    J Immunol; 2015 Apr; 194(7):3180-90. PubMed ID: 25725100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor necrosis factor alpha and CD40 ligand antagonize the inhibitory effects of interleukin 10 on T-cell stimulatory capacity of dendritic cells.
    Brossart P; Zobywalski A; Grünebach F; Behnke L; Stuhler G; Reichardt VL; Kanz L; Brugger W
    Cancer Res; 2000 Aug; 60(16):4485-92. PubMed ID: 10969796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sequential delivery of maturation stimuli increases human dendritic cell IL-12 production and enhances tumor antigen-specific immunogenicity.
    Kalady MF; Onaitis MW; Emani S; Abdel-Wahab Z; Tyler DS; Pruitt SK
    J Surg Res; 2004 Jan; 116(1):24-31. PubMed ID: 14732346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adenovirus-mediated CD40 ligand gene-engineered dendritic cells elicit enhanced CD8(+) cytotoxic T-cell activation and antitumor immunity.
    Liu Y; Zhang X; Zhang W; Chen Z; Chan T; Ali K; Jia Z; Xiang J
    Cancer Gene Ther; 2002 Feb; 9(2):202-8. PubMed ID: 11857039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The duration of signaling through CD40 directs biological ability of dendritic cells to induce antitumor immunity.
    Watanabe S; Kagamu H; Yoshizawa H; Fujita N; Tanaka H; Tanaka J; Gejyo F
    J Immunol; 2003 Dec; 171(11):5828-36. PubMed ID: 14634092
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elderly dendritic cells respond to LPS/IFN-γ and CD40L stimulation despite incomplete maturation.
    Gardner JK; Cornwall SMJ; Musk AW; Alvarez J; Mamotte CDS; Jackaman C; Nowak AK; Nelson DJ
    PLoS One; 2018; 13(4):e0195313. PubMed ID: 29652910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytotoxic activity of human dendritic cells is differentially regulated by double-stranded RNA and CD40 ligand.
    Vidalain PO; Azocar O; Yagita H; Rabourdin-Combe C; Servet-Delprat C
    J Immunol; 2001 Oct; 167(7):3765-72. PubMed ID: 11564793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potent maturation of monocyte-derived dendritic cells after CD40L lentiviral gene delivery.
    Koya RC; Kasahara N; Favaro PM; Lau R; Ta HQ; Weber JS; Stripecke R
    J Immunother; 2003; 26(5):451-60. PubMed ID: 12973034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune Check Point CD40-CD40L Activates Dendritic and Effector Cells Against Human Renal Carcinoma Cells.
    Hillebrand RM; Vogt A; Strassburg CP; Gonzalez-Carmona MA; Schmidt-Wolf IGH
    Anticancer Res; 2019 Sep; 39(9):4643-4652. PubMed ID: 31519562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IL-12p70 production by Leishmania major-harboring human dendritic cells is a CD40/CD40 ligand-dependent process.
    Marovich MA; McDowell MA; Thomas EK; Nutman TB
    J Immunol; 2000 Jun; 164(11):5858-65. PubMed ID: 10820265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Susceptibility of human dendritic cells (DCs) to measles virus (MV) depends on their activation stages in conjunction with the level of CDw150: role of Toll stimulators in DC maturation and MV amplification.
    Murabayashi N; Kurita-Taniguchi M; Ayata M; Matsumoto M; Ogura H; Seya T
    Microbes Infect; 2002 Jul; 4(8):785-94. PubMed ID: 12270725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination of monocyte-derived dendritic cells and activated T cells which express CD40 ligand: a new approach to cancer immunotherapy.
    Sato T; Terai M; Yasuda R; Watanabe R; Berd D; Mastrangelo MJ; Hasumi K
    Cancer Immunol Immunother; 2004 Jan; 53(1):53-61. PubMed ID: 13680192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distinct effect of CD40 and TNF-signaling on the chemokine/chemokine receptor expression and function of the human monocyte-derived dendritic cells.
    Xia Y; Dai J; Lu P; Huang Y; Zhu Y; Zhang X
    Cell Mol Immunol; 2008 Apr; 5(2):121-31. PubMed ID: 18445342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human dendritic cells activate T lymphocytes via a CD40: CD40 ligand-dependent pathway.
    McLellan AD; Sorg RV; Williams LA; Hart DN
    Eur J Immunol; 1996 Jun; 26(6):1204-10. PubMed ID: 8647193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of ex vivo culture duration on phenotype and cytokine production by mature dendritic cells derived from peripheral blood monocytes.
    Tawab A; Fan Y; Read EJ; Kurlander RJ
    Transfusion; 2009 Mar; 49(3):536-47. PubMed ID: 19243546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipopolysaccharide modulation of dendritic cells is insufficient to mature dendritic cells to generate CTLs from naive polyclonal CD8+ T cells in vitro, whereas CD40 ligation is essential.
    Kelleher M; Beverley PC
    J Immunol; 2001 Dec; 167(11):6247-55. PubMed ID: 11714787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of CD68+lin- peripheral blood cells with dendritic precursor characteristics.
    Strobl H; Scheinecker C; Riedl E; Csmarits B; Bello-Fernandez C; Pickl WF; Majdic O; Knapp W
    J Immunol; 1998 Jul; 161(2):740-8. PubMed ID: 9670950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Collagen induces maturation of human monocyte-derived dendritic cells by signaling through osteoclast-associated receptor.
    Schultz HS; Nitze LM; Zeuthen LH; Keller P; Gruhler A; Pass J; Chen J; Guo L; Fleetwood AJ; Hamilton JA; Berchtold MW; Panina S
    J Immunol; 2015 Apr; 194(7):3169-79. PubMed ID: 25725106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medroxyprogesterone acetate impairs human dendritic cell activation and function.
    Quispe Calla NE; Ghonime MG; Cherpes TL; Vicetti Miguel RD
    Hum Reprod; 2015 May; 30(5):1169-77. PubMed ID: 25740884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dendritic cells rapidly undergo apoptosis in vitro following culture with activated CD4+ Valpha24 natural killer T cells expressing CD40L.
    Nieda M; Kikuchi A; nicol A; Koezuka Y; Ando Y; Ishihara S; Lapteva N; Yabe T; Tokunaga K; Tadokoro K; Juji T
    Immunology; 2001 Feb; 102(2):137-45. PubMed ID: 11260318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.